Full Breakdown
Senate Hearing on Dr. Casey Means: Psilocybin Use Under Scrutiny
2/26/2026, 2:58:40 AM
Confirmation Hearing Overview
During a recent confirmation hearing before the Senate Health, Education, Labor, and Pensions Committee, Dr. Casey Means, nominated by President Donald Trump for the position of Surgeon General, faced intense questioning from Senator Susan Collins (R-Maine) regarding her past advocacy for psilocybin, commonly known as magic mushrooms. Collins expressed concern over Means' recommendation of psilocybin-assisted therapy in her 2024 book, "Good Energy," highlighting the ongoing issues of addiction and drug overdoses in the United States.
Key Statements from the Hearing
Senator Collins directly questioned Means about her encouragement for individuals to consider psilocybin therapy, citing the serious implications of illicit drug use. "Illicit drug use remains a huge problem in this country," Collins stated, pressing Means to clarify her stance. In response, Means differentiated her personal views from those she would hold as a public health official, stating, "I believe what I would say as a private citizen is in many cases different than what I would say as a public health official."
Means acknowledged the emerging science surrounding psychedelic therapy for mental health issues, particularly for veterans with PTSD, but firmly stated, "It would certainly not be a recommendation to the American people to do that, under no circumstances." She emphasized the importance of evidence-based communication in her potential role as Surgeon General.
Background on Psilocybin
Psilocybin is classified as a Schedule 1 substance under the Controlled Substances Act, indicating a high potential for abuse and no accepted medical use in the U.S. This classification places it alongside other substances like heroin and LSD. The Drug Enforcement Administration notes that psilocybin can cause various adverse effects, including nausea, hallucinations, and panic reactions.
Criticism and Concerns
Collins reiterated her concerns about Means' past use of psychedelics, particularly referencing a passage in "Good Energy" where Means described an "internal voice" that prompted her to explore psychedelics. Means clarified that this reference was tied to her mother's diagnosis of pancreatic cancer, stating, "In that passage of the book, I’m referring to my mother’s passing... I was having a deep sense that something ominous was coming."
Official Statements and Responses
Means expressed her commitment to sharing scientifically supported health information, stating, "I look forward to working with you on these issues that are so important." She acknowledged the ongoing research into psychedelic therapies, describing it as "some of the most promising and exciting" work in the field.
Conclusion
The confirmation hearing for Dr. Casey Means highlighted the complexities surrounding the discussion of psilocybin and its potential therapeutic uses. As the Senate deliberates her nomination, the dialogue reflects broader societal concerns regarding drug use and public health messaging.
